Home β€Ί Stories β€Ί Stocks
🟑 Watch

Moderna's Melanoma Vaccine Trial Ignites Chatter

Moderna and Merck announced a positive Phase 3 melanoma trial, but reported stock gains conflict and no price was captured.

Buzz velocity13.0Γ—

What's happening

Moderna and Merck said their mRNA neoantigen therapy met its primary endpoint in a Phase 3 melanoma trial by cutting recurrence, and several outlets called it a historic result for cancer vaccines. Headlines reported shares doubling, rising over 115%, and, in a Russian-language post, rising 150% in a single day. No price feed was captured to confirm any of those moves.

The numbers

No price was captured for MRNA, so none of the reported moves can be checked here. Chatter was 13 recent mentions across 3 sources, with a velocity of 13.0.

Our read

Watch - the trial result looks real since Merck co-announced it, but the size of the reported price pop is unverified and inconsistent across sources. Confirm against MRNA's actual tape before repeating any single number.

Context

No earlier Sort Brick stories on Moderna appear in this set, and no price history was captured, so the comparison relies on later stories and chatter counts. Later Sort Brick stories on Moderna are dated October 6 and October 23 and carry real and fake verdicts. One October 23 story reports the stock dropping as much as 26% on a reported data leak, while a same-day story rates the leak chatter fake because the price shows only a 1.5% gain. The later verdicts run in both directions, the same mismatch between chatter and price that the August 19 coverage shows.

Sources we checked

See today's live board

This story is frozen as published on August 19, 2026. The live board shows what is moving right now, scored against real money.

Open this story live β†’ See today's live board

More Stocks stories

Research, not financial advice. Sort Brick reports what its data showed at the time of publication. It is not a recommendation to buy or sell anything β€” you decide.

Get Sort Brick Daily - free, every evening

One short email every evening: what really moved, what was only noise, and what we logged first, with the times. Free. Information, not investment advice.

No spam. One click to unsubscribe. Sent by Sort Brick.